113 related articles for article (PubMed ID: 8175079)
1. [Hypotensive action of human renin inhibitor KRI-1314 in the common marmoset].
Saitoh H; Etoh Y; Murakami M; Kubota T; Miyazaki M
Nihon Yakurigaku Zasshi; 1994 Apr; 103(4):161-73. PubMed ID: 8175079
[TBL] [Abstract][Full Text] [Related]
2. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
Miyazaki M; Etoh Y; Iizuka K; Toda N
J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609
[TBL] [Abstract][Full Text] [Related]
3. KRI-1314: an orally effective inhibitor of human renin.
Etoh Y; Miyazaki M; Saitoh H; Toda N
Jpn J Pharmacol; 1993 Sep; 63(1):109-19. PubMed ID: 8271523
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor.
Shibasaki M; Asano M; Fukunaga Y; Usui T; Ichihara M; Murakami Y; Nakano K; Fujikura T
Am J Hypertens; 1991 Dec; 4(12 Pt 1):932-8. PubMed ID: 1815649
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravenous recombinant human renin on blood pressure in pithed spontaneously hypertensive rats.
Shibasaki M; Sudoh K; Asano M; Murakami K
Eur J Pharmacol; 1992 May; 215(2-3):271-6. PubMed ID: 1396991
[TBL] [Abstract][Full Text] [Related]
6. Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets.
Wood JM; Baum HP; Jobber RA; Neisius D
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S96-8. PubMed ID: 2485073
[TBL] [Abstract][Full Text] [Related]
7. Effects of a specific and long-acting renin inhibitor in the marmoset.
Wood JM; Gulati N; Forgiarini P; Fuhrer W; Hofbauer KG
Hypertension; 1985; 7(5):797-803. PubMed ID: 3928488
[TBL] [Abstract][Full Text] [Related]
8. Effect of renin inhibitor, ES-8891, on renal renin secretion and storage in the marmoset: comparison with captopril.
Ii Y; Murakami E; Hiwada K
J Hypertens; 1991 Dec; 9(12):1119-25. PubMed ID: 1663967
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogs.
Wessale JL; Calzadilla SV; Boyd SA; Baker WR; Stein HH; Kovar PJ; Barlow J; Klinghofer V; Mantei R; Kleinert HD
J Cardiovasc Pharmacol; 1993 Oct; 22(4):644-52. PubMed ID: 7505369
[TBL] [Abstract][Full Text] [Related]
10. [Hypotensive effect of a human anti-renin monoclonal antibody (4G1D8) in the sodium-depleted alert marmoset].
Cazaubon C; Carlet C; Richaud JP; Nisato D; Corvol P; Gagnol JP
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):840-6. PubMed ID: 3099700
[TBL] [Abstract][Full Text] [Related]
11. Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerations.
Palmer RK; Rapundalo ST; Batley BL; Barnes AE; Singh S; Ryan MJ; Taylor DG
Clin Exp Hypertens; 1993 Jul; 15(4):663-81. PubMed ID: 8374609
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
Kleinert HD; Martin D; Chekal M; Young G; Rosenberg S; Plattner JJ; Perun TJ
J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of renin inhibitor GR70982 in the conscious marmoset.
Gardner CJ; Twissell DJ; Charlton PA; Cherry PC
Eur J Pharmacol; 1991 Jan; 192(3):329-35. PubMed ID: 1905233
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
[TBL] [Abstract][Full Text] [Related]
15. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
Wood JM; Schnell CR; Cumin F; Menard J; Webb RL
J Hypertens; 2005 Feb; 23(2):417-26. PubMed ID: 15662231
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect on reduction in blood pressure with coadministration of the renin inhibitor, CP-80,794, and the angiotensin converting enzyme inhibitor, captopril.
Fossa AA; Weinberg LJ; Barber RL; Rauch AL; Nocerini MR; Murphy WR; Swindell AC
J Cardiovasc Pharmacol; 1992 Jul; 20(1):75-82. PubMed ID: 1383634
[TBL] [Abstract][Full Text] [Related]
18. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.
Lacour C; Cazaubon C; Roccon A; Segondy D; Wagnon J; Nisato D
J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of acute and chronic renin inhibition in marmosets.
Wood JM; Baum HP; Forgiarini P; Gulati N; Jobber RA; Neisius D; Hofbauer KG
J Hypertens Suppl; 1989 Apr; 7(2):S37-42. PubMed ID: 2547039
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and cardiovascular effects of YM-21095, a novel renin inhibitor, in dogs and monkeys.
Shibasaki M; Usui T; Inagaki O; Asano M; Takenaka T
J Pharm Pharmacol; 1994 Jan; 46(1):68-72. PubMed ID: 8201530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
